Management of Neurogenic Bladder and Sexual Dysfunction in Spinal Cord Injury
Clean intermittent catheterization combined with antimuscarinic medications is the gold standard treatment for neurogenic bladder in patients with spinal cord injury, while addressing sexual dysfunction should be prioritized as it ranks among top patient expectations one year after injury. 1, 2
Neurogenic Bladder Management
Assessment and Diagnosis
Urodynamic studies are essential to determine the exact type of bladder dysfunction:
- Detrusor overactivity (most common, ~48% of cases)
- Impaired detrusor contractility (30%)
- Poor bladder compliance (15%)
- Detrusor-sphincter dyssynergia 1
Regular monitoring is crucial:
- Renal ultrasound every 6-12 months to assess for hydronephrosis
- Urodynamic studies at baseline and periodically (every 1-2 years)
- Post-void residual (PVR) measurement (>100mL indicates need for catheterization) 1
First-Line Treatment
Clean Intermittent Catheterization (CIC)
- Gold standard for treating voiding disorders in neurogenic bladder 1, 2
- Recommended frequency: every 4-6 hours while awake
- Target volume: <500mL per catheterization to prevent bladder over-distension
- Adjust frequency based on volumes obtained 1
- Associated with lower incidence of UTI compared to indwelling catheters 3
Pharmacological Management
Antimuscarinic medications (high-strength evidence):
- First-line for detrusor overactivity (e.g., oxybutynin 0.2 mg/kg three times daily)
- Improves bladder storage parameters and decreases incontinence episodes 1
Beta-3 adrenergic receptor agonists (moderate-strength evidence):
- Alternative or adjunct when antimuscarinic side effects are problematic
- Example: mirabegron 1
Alpha-blockers (low-strength evidence):
Behavioral Techniques
- Timed voiding schedule every 2-3 hours during waking hours
- Urgency suppression techniques
- Fluid management (2-3L per day unless contraindicated)
- Avoid bladder irritants (caffeine, alcohol, acidic foods)
- Maintain bladder diary documenting fluid intake, voiding times/volumes, and incontinence episodes 1
UTI Prevention
- Adequate hydration (2-3L/day unless contraindicated)
- Proper aseptic technique for catheterization
- Avoid reusing catheters
- Do not treat asymptomatic bacteriuria 3, 1
- Antibiotic prophylaxis should only be considered for patients with frequent UTIs (≥3 per year) that chronically impair function and well-being 3
Advanced Treatment Options for Refractory Cases
For patients who fail first-line therapy due to inefficacy or intolerability:
Endoscopic Management
Surgical Options
Neuromodulation
Sexual Dysfunction Management
Sexual dysfunction must be addressed as it ranks among top patient expectations one year after injury 2.
- SARS-SDAF has shown positive effects on sexual function with satisfaction rates of 5/10 for females and 8/10 for males 7
- Sexual function assessment should be part of regular follow-up
Monitoring and Follow-up
Regular follow-up is essential to protect renal function and prevent complications:
- Almost all patients require treatment modifications over time 6
- In a long-term study, only 3 out of 80 patients maintained the same treatment throughout follow-up 6
- Regular urodynamic assessment is crucial for maintaining bladder function and preventing upper urinary tract damage 6
Complications to Monitor and Prevent
Untreated neurogenic bladder can lead to:
- Recurrent urinary tract infections
- Upper urinary tract deterioration
- Renal failure
- Bladder stones
- Poor quality of life 1, 5
By implementing appropriate management strategies and regular monitoring, these complications can be minimized, significantly improving patient outcomes and quality of life.